openPR Logo
Press release

Viscosupplementation Market By Source, Type, Application and is Growing With a CAGR of 8.5% Forecast period of 2022 to 2029

11-28-2022 06:34 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

/ PR Agency: DBMR
Viscosupplementation Market

Viscosupplementation Market

Data Bridge Market research has a newly released expansive study titled "Viscosupplementation Market" which guarantees you will remain better informed than your competition. This study provides a broader perspective of the marketplace with its comprehensive market insights and analysis which eases survival and success in the market.

Global viscosupplementation market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 8.5% in the forecast period of 2022 to 2029. Technological advancements in viscosupplementation treatments rise in the healthcare sector are another factor that drives the growth of the global viscosupplementation market in the forecast period.

However, the high cost associated with the treatments and side effects such as temporary injection, site pain, swelling, heat, and redness loss will restrain the market's growth. Adoption of strategic alliances like partnerships and acquisitions by key market players act as an opportunity for the growth of the global viscosupplementation market.

Download the Free PDF Sample Report (Including FULL TOC, Graphs, and Tables) of this report @



Viscosupplementation Market Definition

The development of the therapeutic paradigm viscosupplementation for long-lasting pain relief in human and animal joints with osteoarthritis or traumatic arthritis was based on the finding that in arthritic conditions, the average molecular weight and concentration of hyaluronan decreased. Consequently, the elastoviscous properties of the synovial fluid are substantially reduced. Viscosupplementation is a therapeutic process in which the pathological synovial fluid or effusion is removed from the joint by arthrocentesis and is replaced with a highly purified hyaluronan solution which has a 16- to 30-times greater concentration than the pathological joint fluid, and a 2- to 5-times greater concentration than that of the hyaluronan in the healthy synovial fluid. In some preparations of hyaluronan used today for therapeutic purposes, the rheological properties (viscosity and elasticity) are low. Therefore the elastoviscosity of the fluid is similar to that of fluid removed from an arthritic joint. Another preparation available to patients worldwide is composed of hyaluronan derivatives (hylans) with substantially greater elastoviscosity than hyaluronan solutions. It has comparable rheological properties to the fluid found in young, healthy individuals. The clinical benefit of viscosupplementation is long-lasting pain relief in arthritic joints.

Furthermore, the increasing demand for non-surgical treatments for osteoarthritis, the prevalence of lifestyle-induced disorders, and advancements in the development of hyaluronic acid-based therapies are some of the factors expected to drive the market. 

Market Dynamics                                        


Rising geriatric population

With this increasing age comes a reciprocal increase in the elderly patients admitted to the hospitals due to fatal traumatic injuries. The rising prevalence of knee osteoarthritis diseases leads to increasing demand for diagnosis and treatment. With the growing population, the pressure on the healthcare system is rising. The increasing need for the proper treatment proportionally surges the demand for care, services, and technologies for the prevention and treatment of knee osteoarthritis conditions such as sarcopenia, osteoporosis, osteopenia, and other complications. The elderly population is more prone to these conditions leading to fragile bones and joints. In such patients, viscosupplementation is used in the procedure to provide them with immediate and efficient benefits associated with their bodies.

With this increasing age and rising prevalence of osteoarthritis, the demand for early diagnosis of the diseases is also increasing. Therefore, the demand for viscosupplementation is rising for the treatment in the healthcare system across the globe.

Increasing risk of osteoporosis and osteoarthritis

Osteoporosis is a disease of bone that progresses due to less bone mineral density and bone mass or due to some variation in the quality or structure of bone. Osteoporosis could increase the risk of fractures leading to broken bones due to decreased bone strength. It is more observed in women as compared to men. The post-menstrual women often get bone fractures due to osteoporosis as the disease is silent and typically shows no symptoms. Mostly elderly people are more prone to osteoporosis. Osteoarthritis is a joint disease or an inflammation of the joints and surrounding tissues. The mobility of a person is affected when such conditions occur.

The silent diseases such as osteoporosis and osteoarthritis show no symptoms and weaken the person's bone, leading to major fatalities such as spine malformation, fracture, sudden fall, or breakage of bone, among others. Thus, the increased risks of these conditions directly enhance the demand for viscosupplementation required to treat the malformations due to such conditions. Therefore, the increasing risk of osteoporosis and osteoarthritis is anticipated to drive the growth of the global viscosupplementation market.


Lack of technical expertise

Finding, attracting, and hiring talent is also the first step in building a professional bench of engineers and technicians. Even in the best of circumstances, this procedure can be challenging. Manufacturing existing workforce is rapidly aging and retiring. In the medical industry, there is a scarcity of STEM (science, technology, engineering, and mathematics) skills. Although demand for skilled tradespeople (technicians) and undergraduate/post-graduate skills (engineers) remains strong in manufacturing, the number of people with the necessary skills is approaching a trickle. Only trained professionals should perform viscosupplementation, but this number is much less across the globe as these procedures are complex.

However, putting together a good additive manufacturing (AM) workforce entails more than just finding and recruiting qualified candidates. Employees must be qualified to remain current and maintain required skills as technology shift and grow. Even with their STEM-focused education, newly minted engineers would certainly need on-the-job training in AM techniques, which is one of the major challenges of recruiting and hiring them. Indeed, many undergraduate engineering programs provide little in the way of AM-specific education, and as a result, many graduates can lack the AM skills that employers seek.

Thus, the lack of technical expertise may act as a restraint for the market's growth.

View Detailed Report@

Post COVID-19 Impact on Global Viscosupplementation Market

COVID-19 has resulted in a substantial increase in demand for medical supplies from healthcare professionals and the general public for precautionary measures. Manufacturers of these items have an opportunity to take advantage of the increased demand for medical supplies by ensuring a steady supply of personal protective equipment on the market. COVID-19 is anticipated to have a big impact on the global viscosupplementation market.

Global Viscosupplementation Market Scope and Market Size

Global viscosupplementation market is segmented on the basis of source, age group, molecular weight, injection, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the Difference in your target markets.




On the basis of source, the global viscosupplementation market is segmented into the animal origin and non-animal origin.





On the basis of molecular weight, the global viscosupplementation market is segmented into intermediate molecular weight, low molecular weight, and high molecular weight.





On the basis of injection, the global viscosupplementation market is segmented into single injection, three injections, and five injections.




On the basis of age group, the global viscosupplementation market is segmented into geriatric and adults.






On the basis of end-user, the global viscosupplementation market is segmented into hospital, orthopedic clinics, ambulatory care centers, and others.




The complete Report is available (Including the full TOC, Tables, and Figures, Graphs as well as Chart) @

Competitive Landscape and Global Viscosupplementation Market Share Analysis

Global viscosupplementation market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to viscosupplementation treatments.

The major companies which are dealing in the viscosupplementation market are Anika Therapeutics, Inc., SEIKAGAKU CORPORATION, Bioventus, Fidia Farmaceutici S.P.A, Ferring B.V,  sanofi-aventis U.S. LLC, Zimmer Biomet, OrthogenRx, Inc. (a subsidiary of AVNS),  APTISSEN, Johnson & Johnson Services, Inc., LG Chem., Viatris Inc., IBSA Institut Biochimique SA, Ortobrand International, TRB CHEMEDICA SA, Teva Pharmaceutical Industries Ltd., Lifecore (a subsidiary of Landec Corporation), VIRCHOW BIOTECH, Zuventus HealthCare Ltd. (a subsidiary of Emcure Pharmaceuticals), among others

Strategic alliances like mergers, acquisitions, and agreements by the key market players are further expected to accelerate the growth of viscosupplementation treatments.

For instance,

In June 2022, Johnson & Johnson announced new data from Phase 3 studies demonstrating patients treated with medicine achieved consistent, long-term efficacy through two years across the domains of active psoriatic arthritis (PsA) - including joint, skin, enthesitis, a dactylitis,b spinal pain, and disease severityc endpoints - irrespective of baseline characteristics. This has helped company to showcase its progress

In November 2020, Viatris Inc. launched a successful combination of Mylan N.V. and Pfizer's Upjohn business. By combining these two complementary legacy companies, Viatris has the scientific, manufacturing, and distribution expertise with proven regulatory, medical and global commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. This has helped company to expand its business

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios of the top players in the Medical Display market

Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product launches in the market

Competitive Assessment: In-depth assessment of the market strategies, and geographic and business segments of the leading players in the market

Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies

Key Questions Answered in This Report:
How does our product and services portfolio compare to leading competitors?
What are the key developments in customer demand given the changing economy?
What are the new pricing and consumption models in the marketplace and how should we align our portfolio?
What are the key decision drivers for services buyers?
How can we accelerate our bidding process?
What is the potential of this Market?
What is the impact of COVID-19 on this Market?
What are the top strategies that companies adopting in this Market?
What are the challenges faced by SME's and prominent vendors in this Market?
Which region has the highest investments in this Market?
What are the latest research and activities in this Market?
Who are the prominent players in this Market?
What is the potential of the this Market?

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-
Data Bridge Market research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viscosupplementation Market By Source, Type, Application and is Growing With a CAGR of 8.5% Forecast period of 2022 to 2029 here

News-ID: 2823024 • Views: 222

More Releases from Data Bridge Market Research

Cancer Treatment Market Set to Reach Valuation of USD 524,921.84 Million with gr …
Cancer Treatment Market research covers impacts on the upstream, midstream and downstream industries. Also, this study offers a detailed market estimates by emphasizing statistics on several aspects covers market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. Global Cancer Treatment Market report has been prepared by keeping in mind the customer requirements which assist them in increasing their return on investment (ROI). Furthermore, it endows with historic data,
Europe Offsite Sterilisation Service Market to Receive USD 962.00 Million with C …
Europe Offsite Sterilisation Service Market" published by Data Bridge Market Research includes growth analysis, regional marketing, challenges, opportunities, and drivers analyzed in the report. Data Bridge Market Research also includes in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand. The market overview is given in terms of drivers, restraints, opportunities, and
North America Textile Films Market - Industry Trends and Forecast to 2027
The textile films market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses that the market is growing at a CAGR of 6.3% in the forecast period of 2020 to 2027 and expected to reach USD 2,241,796.79 thousand 2027. North America Textile Films business report gives explanation about the vital developments in the market which range from the crucial improvements
Europe Anti-Nuclear Antibody Test Market - Industry Trends and Forecast to 2029
Data Bridge Market Research analyses that the anti-nuclear antibody test will exhibit a CAGR of around 12.79% for the forecast period of 2022-2029. Europe Anti-Nuclear Antibody Test business report gives explanation about the vital developments in the market which range from the crucial improvements of the market, containing research and development, new item dispatch, pronouncement, coordinated efforts, associations, joint aspire, and territorial development of the key rivals working in the

All 5 Releases

More Releases for Viscosupplementation

Viscosupplementation Market-entry and expansion strategies
MarketResearchReports.Biz adds “Global Viscosupplementation Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Viscosupplementation and the growth estimates for the forecasted period. The main objective of this report is to aid the user in understanding the market as a whole, its definitions, segmentation, market potential, influential trends, and the barriers that it is facing. Meticulous research and analysis were
Global Viscosupplementation - Analysis and Market Forecasts
"The Report MediPoint: Viscosupplementation - Global Analysis and Market Forecasts provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -" About Viscosupplementation Market Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability across the globe. Intra-articular viscosupplementation with hyaluronic acid (HA) has become an increasingly accepted therapeutic alternative to knee replacement surgery in the
Viscosupplementation Market : Analysis and Forecast by 2023
Viscosupplementation is a minimally invasive procedure that involves injection of gel-like substances into a joint to assist the viscous properties of synovial fluid. As of now hyaluronate injections are only approved viscosupplementation treatment of osteoarthritis of the knee. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Hyaluronic acid is observed to be an integral component of
Look Inside Viscosupplementation Market - Growth after 2017
Qyresearchreports include new market research report Global Viscosupplementation Sales Market Report 2017 to its huge collection of research reports. This report on the global Viscosupplementation market has been curated by research analysts of the industry, with a chief aim to put forth the current market conditions for the global Viscosupplementation. Its objective is to shed light on the prospects of growth of the market and reach out to a wide range
Viscosupplementation Market: Three Injection Viscosupplementation Likely to be t …
Latest industry research report on: Viscosupplementation Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Single injection viscosupplementation segment is anticipated to record the highest CAGR during the projected period The single injection viscosupplementation segment in the Russia viscosupplementation market is expected to expand at the fastest and highest CAGR of 6.0% over the forecast period, due to relatively less competition across the product type segments. Complete
Viscosupplementation Market | Analysis & Key Trends 2023
Viscosupplementation is a minimally invasive procedure that involves injection of gel-like substances into a joint to assist the viscous properties of synovial fluid. As of now hyaluronate injections are only approved viscosupplementation treatment of osteoarthritis of the knee. Hyaluronic acid (HA) or hyaluronate is a non-sulfated glycosaminoglycan that is distributed throughout the body in epithelial, connective tissues, and neural tissues. Hyaluronic acid is observed to be an integral component of